Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | Foxberry Medical Cannabis & Life Sciences |
| Investment focus | Equity, World, Health Care |
| Fund size | EUR 13 m |
| Total expense ratio | 0.65% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 25.24% |
| Inception/ Listing Date | 12 February 2020 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | ARK Invest International |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | Northern Trust International Fund Administration Services (Ireland) Limited |
| Investment Advisor | |
| Custodian Bank | Northern Trust Fiduciary Services (Ireland) Limited |
| Revision Company | Deloitte Ireland LLP |
| Fiscal Year End | 1 June |
| Swiss representative | 1741 Fund Solutions AG |
| Swiss paying agent | Tellco AG |
| Germany | Unknown |
| Switzerland | ESTV Reporting |
| Austria | Non-Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | No |
| Securities lending counterparty |
| Scotts Miracle-Gro Co. | 19.14% |
| Perrigo Co | 15.99% |
| Jazz Pharmaceuticals | 15.37% |
| Revvity | 14.19% |
| GrowGeneration | 8.44% |
| Teva Pharmaceutical Inds | 6.29% |
| Novartis AG | 6.08% |
| AbbVie, Inc. | 5.88% |
| CARA Therapeutics | 5.41% |
| Hydrofarm Holdings Group | 1.29% |
| United States | 55.33% |
| Ireland | 31.37% |
| Other | 13.30% |
| Health Care | 58.70% |
| Basic Materials | 19.14% |
| Consumer Discretionary | 8.44% |
| Industrials | 1.29% |
| Other | 12.43% |
| YTD | -29.71% |
| 1 month | +4.30% |
| 3 months | -10.19% |
| 6 months | -22.40% |
| 1 year | -30.96% |
| 3 years | -64.47% |
| 5 years | - |
| Since inception (MAX) | -58.01% |
| 2024 | -43.90% |
| 2023 | -13.07% |
| 2022 | - |
| 2021 | - |
| Volatility 1 year | 25.24% |
| Volatility 3 years | 37.00% |
| Volatility 5 years | - |
| Return per risk 1 year | -1.23 |
| Return per risk 3 years | -0.79 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -44.01% |
| Maximum drawdown 3 years | -80.97% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -80.97% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | BLUM | - - | - - | - |
| London Stock Exchange | GBP | FLWG | - - | - - | - |
| London Stock Exchange | GBX | FLWG | FLWG LN BLUMEUIV | FLWG.L BLUMEURINAV=SOLA | Societe Generale |
| London Stock Exchange | USD | FLWR | FLWR LN BLUMEUIV | FLWR.L BLUMEURINAV=SOLA | Societe Generale |
| SIX Swiss Exchange | CHF | FLWR | FLWR SE BLUMEUIV | FLWR.S BLUMEURINAV=SOLA | Societe Generale |
| XETRA | EUR | BLUM | BLUM GY BLUMEUIV | BLUM.DE BLUMEURINAV=SOLA | Societe Generale |